Locations:
Search
Treatment effective post-ruxolitinib failure
Multi-center study indicates benefit is associated with risk stratification and the utilization of radiation therapy
Germline testing of 400 patients shows that more than one in seven have an inherited risk for cancer
Young-onset disease presentation on the rise
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
How online education is redefining the patient-provider relationship
Bcl-xL inhibitors may help overcome this complication
Community-based data help predict patients’ response to immune checkpoint inhibitors
New findings may lead to less-toxic tumor therapies
Common cancer therapy increases serious risks in murine models
Study suggests new approach is safer than standard treatment and may help prevent graft-versus-host disease
Advertisement
Advertisement